Aspiriant LLC’s Eagle Capital Select Equity ETF EAGL Stock Holding History

Aspiriant LLC’s Portfolio EAGL Stock Details EAGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	+58,062	New	+$1.88M	0.05%	124

Other funds holding EAGL

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

RCWVOTCITCONY

Rector, Church-Wardens & Vestrymen of Trinity Church in the city of New-York New York $435M AUM 15.06% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

SWM

Sendero Wealth Management San Antonio, Texas $1B AUM 24.51% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RDWM

Red Door Wealth Management Memphis, Tennessee $1.1B AUM 31.77% 1-Year Est. Return

Aspiriant LLC's EAGL Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Eagle Capital Select Equity ETF (EAGL) in Q2 2026: 58,062 shares worth $1.87M. The stake represents 0.05% of the portfolio and ranks #124 among its holdings.

69 funds tracked by Wall St. Rank hold EAGL as of Q2 2026.

Aspiriant LLC held 58,062 shares of Eagle Capital Select Equity ETF worth $1.87M as of Q2 2026.
Eagle Capital Select Equity ETF was a new Aspiriant LLC position in Q2 2026.
Eagle Capital Select Equity ETF made up 0.05% of Aspiriant LLC's portfolio in Q2 2026, its #124 holding.
69 funds tracked by Wall St. Rank held Eagle Capital Select Equity ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.